Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...the trading day were intense, with gauges of volatility surging to the highest levels since since October 2020, ahead of the US election and results of the effectiveness of vaccines being developed by Pfizer...
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Virgin Louis V on my back, baby. Living fast, dying slow, that's the catch, baby. Suicide doors, [MUTED] around and crash, baby. I do the dash, baby....
...There are a lot of stories about what could go wrong — most notably uncertainty on trade,” said David Kelly, chief global strategist at JPMorgan Asset Management....
...Last year, Aengus Kelly, the Irish chief executive of AerCap, the world’s biggest aircraft leasing company, moved his fleet to Ireland....
...New Hampshire senator Kelly Ayotte, Hassan’s Republican rival, refusing to say twice if she trusted Trump having access to the nuclear codes....
...(FT) Murdoch v Trump: Fox and The Hair Donald Trump has gone to war with an unlikely enemy....
...He has played an important role in many recent cross-border deals involving the UK including helping AstraZeneca fight off a bid from Pfizer....
...Pfizer had agreed to donate Zithromax, a highly effective antibiotic that proved popular with people not just because it knocked out trachoma, but other lingering illnesses as well....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Kelly Martin, Elan’s chief executive, who joined a decade ago after a career at Merrill Lynch, has made his mark through restructuring the business, reducing debts and engineering spin-offs and licensing...
...“The restructuring of this business collaboration provides Elan with significant strategic flexibility,” said Kelly Martin, Elan’s chief executive, on Wednesday....
...He describes turning up to the Monterey Pop Festival in 1967 wearing “a V-neck tennis sweater in the traditional white, maroon and black, over white pants”....
...Chief executive Kelly Martin, who was due to depart in May, was kept on to shepherd the Alzheimer’s trials. The board needs to name a successor to look at all the options....
...Elan’s partners Pfizer and Janssen, part of Johnson & Johnson, which are running the tests, have said trial results are due in the second half of this year....
...Drugmaker Pfizer added 2.1 per cent to $23.62, while Merck rose 0.8 per cent to $44.17, its highest level in more than four years....
...Robert Kelly Ortberg, executive vice-president for government systems in Rockwell Collins, the producer of electronics to the air industry, said: “Just like every other US company, we are looking to the...
...This year the measure is expected to be on the ballot at 25 companies, including Pfizer, JP Morgan Chase and Verizon....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Back on earth, Gavin and Kelly were able to reprogramme the landing craft to tow the crippled command module 300,000 miles round the moon and earthwards....
...Some pharmaceutical stocks fell, with Eli Lilly declining 0.8 per cent to $34.99 and Pfizer dropping by 1 per cent to $16.83....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
International Edition